LETROZOLE CIPLA letrozole 2.5mg film-coated tablet blister pack

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

letrozole, Quantity: 2.5 mg

Beschikbaar vanaf:

Cipla Australia Pty Ltd

INN (Algemene Internationale Benaming):

Letrozole

farmaceutische vorm:

Tablet, film coated

Samenstelling:

Excipient Ingredients: lactose monohydrate; sodium starch glycollate; microcrystalline cellulose; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 400

Toedieningsweg:

Oral

Eenheden in pakket:

30, 10

Prescription-type:

(S4) Prescription Only Medicine

therapeutische indicaties:

For the treatment of postmenopausal women with hormone receptor positive breast cancer (see Clinical Trials). The safety and efficacy of neoadjuvant use of letrozole has not been established. Letrozole is not indicated in hormone receptor negative disease.

Product samenvatting:

Visual Identification: Yellow circular, biconvex, film coated tablet debossed with LT on one side and 2.5 on the other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Autorisatie-status:

Licence status A

Autorisatie datum:

2016-06-01